Xcenda Supports AMCP Nexus 2020 Virtual
October 12, 2020
As leaders in innovation for over 25 years, our creative, scientific minds of Xcenda have been delivering access “firsts”. We proudly launched the first reimbursement field team, developed the first outcomes analyzer, as well as the concept of the product value proposition—all by staying focused on being patient-first. Connect with us at this virtual event and we'll help you effectively navigate today’s complex healthcare landscape and help you deliver the most distinctive body of evidence that demonstrates your value story.
Xcenda Continues Excellence in Innovative Research
Join us at the AMCP Nexus 2020 Virtual from October 19 through October 23.
We are proud to present the following award-winning research at AMCP. Meet our managed markets and commercialization experts at our virtual booth.
|Trends in Manufacturer Perceptions and Practices Regarding Pre-Approval Information||Jonny Clark, Janet Hughes, Claire Gorey, Amy Duhig, Jay Jackson|
|How Are Curative Therapies Defined by United States Payers?||Anuja Kanaskar, Linnea Tennant, Kimberly Gittings, Chelsey Campbell, Michelle Friedman, Amy Duhig|
|A Descriptive Analysis of Healthcare Decision Maker Engagement Patterns in Pre-Approval Information Exchange||Annie Chang, Minha Choi, Claire Gorey, Breanna Penzner, Jackie Gladman, Amy Duhig|
Digital Therapeutics as a Medical Benefit: Emergence of Published Policies by Managed Care Organizations
|Song Lee, Benjamin Parcher|
|A Review of COVID-19-Related Food and Drug Administration Warning Letters
||Preston Skersick, Andrew Gaiser, Jasmine Knight, Kellie Meyer|